Citation only
via OpenAlex
Improved metabolic control decreases platelet activation markers in patients with type‐2 diabetes
N Eibl, Walter Krugluger, G. Streit, Karl Schrattbauer, P. Hopmeier, Guntram Schernthaner
European Journal of Clinical Investigation · 2004 · ▲ 81 citations
Abstract
BACKGROUND: Cardiovascular disease is associated with platelet dysfunction in patients with diabetes. Hyperglycaemia is known as an independent risk factor for micro- and macrovascular complications, and improvement of metabolic control has shown beneficial effects on diabetic late complications. Our study attempts to clarify the effect of improved metabolic control on platelet activation markers in patients with type-2 diabetes. MATERIALS AND METHODS: Thirty patients were studied at baseline and 3 months after improvement of metabolic control and compared with an age-matched nondiabetic control group. Platelet activation markers (CD31, CD36, CD49b, CD62P and CD63) were assessed by flow cytometry analysis. RESULTS: Significantly more activated platelets were detected in patients with diabetes compared with controls. After 3 months' improvement of metabolic control, a significant decline of all platelet activation markers except CD36 was noted. Furthermore a significant correlation between CD62P, CD63 and HbA(1c) levels was observed. CONCLUSIONS: We conclude therefore that improvement of metabolic control has a beneficial effect on platelet activation. This may have an implication in the pathogenesis of vascular disease in patients with type-2 diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/j.1365-2362.2004.01320.x
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Eibl, N., Krugluger, W., Streit, G., Schrattbauer, K., Hopmeier, P., & Schernthaner, G. (2004). Improved metabolic control decreases platelet activation markers in patients with type‐2 diabetes. <em>European Journal of Clinical Investigation</em>. https://doi.org/10.1111/j.1365-2362.2004.01320.x
Vancouver
Eibl N, Krugluger W, Streit G, Schrattbauer K, Hopmeier P, Schernthaner G. Improved metabolic control decreases platelet activation markers in patients with type‐2 diabetes. European Journal of Clinical Investigation. 2004. doi:10.1111/j.1365-2362.2004.01320.x.
BibTeX
@article{n2004Improv,
title = {Improved metabolic control decreases platelet activation markers in patients with type‐2 diabetes},
author = {N Eibl and Walter Krugluger and G. Streit and Karl Schrattbauer and P. Hopmeier and Guntram Schernthaner},
journal = {European Journal of Clinical Investigation},
year = {2004},
doi = {10.1111/j.1365-2362.2004.01320.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Affective Disorders 2011
Citation only
The role of affective temperaments in metabolic control in patients with type 2 diabetes
Diabetes Care 2002
Open access · OA
The Association Between Diabetes Metabolic Control and Drug Adherence in an Indigent Population
National Journal of Physiology Pharmacy and Pharmacology 2017
Open access · CC-BY
A comparative study of lipid profile, body mass index, and waist circumference among Type 2 diabetes mellitus patients with poor and good metabolic control and normal age-matched control group
American Journal of Clinical Nutrition 2003
Open access · OA
Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes
Journal of the European Academy of Dermatology and Venereology 2013
Citation only
Mean platelet volume is associated with aortic arterial stiffness in patients with Behçet's disease without significant cardiovascular involvement
Diabetes Care 2018
Open access · OA